• Mashup Score: 1
    Long-acting lenacapavir acts as an effective pre-exposure prophylaxis in a rectal SHIV challenge macaque model - 10 month(s) ago

    Long-acting lenacapavir acts as an effective pre-exposure prophylaxis in a rectal SHIV challenge macaque model Last Modified: 08:03 AM, Thu Jul 13, 2023 Bekerman E., Yant S.R., VanderVeen L.A., Hansen D., Lu B., Rowe W. The Journal of clinical investigation. 13 July 2023PrEP_alert Study assessed the efficacy of LEN for PrEP in a…

    Source: infodisplay.infodesk.com
    Categories: Latest Headlines, Manni
    Tweet Tweets with this article
    • Profile photo of MonicaGandhi9
      MonicaGandhi9

      LEN)ACAPAVIR: Now have oral pills (TDF/FTC, TAF/FTC) for pre-exposure prophylaxis (PrEP) & long-acting option (cabotegravir, CAB). Next long-acting option (being tested in large PURPOSE studies) could be lenacapavir 1 shot every 6 months! Works in primates https://t.co/Xbnh4LODTS

    • Profile photo of MonicaGandhi9
      MonicaGandhi9

      LENACAPAVIR: Now have oral pills (TDF/FTC, TAF/FTC) for pre-exposure prophylaxis (PrEP) & long-acting option (cabotegravir, CAB). Next long-acting option (being tested in large PURPOSE studies) could be lenacapavir 1 shot every 6 months! Works in primates https://t.co/Xbnh4LODTS